These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 32618696)

  • 1. Thromboelastography Profiles of Critically Ill Patients With Coronavirus Disease 2019.
    Yuriditsky E; Horowitz JM; Merchan C; Ahuja T; Brosnahan SB; McVoy L; Berger JS
    Crit Care Med; 2020 Sep; 48(9):1319-1326. PubMed ID: 32618696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019.
    Maatman TK; Jalali F; Feizpour C; Douglas A; McGuire SP; Kinnaman G; Hartwell JL; Maatman BT; Kreutz RP; Kapoor R; Rahman O; Zyromski NJ; Meagher AD
    Crit Care Med; 2020 Sep; 48(9):e783-e790. PubMed ID: 32459672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019.
    Hightower S; Ellis H; Collen J; Ellis J; Grasso I; Roswarski J; Cap AP; Chung K; Prescher L; Kavanaugh M; Brown T; Nau M; Clark P
    Thromb Res; 2020 Nov; 195():69-71. PubMed ID: 32659463
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection.
    Wright FL; Vogler TO; Moore EE; Moore HB; Wohlauer MV; Urban S; Nydam TL; Moore PK; McIntyre RC
    J Am Coll Surg; 2020 Aug; 231(2):193-203.e1. PubMed ID: 32422349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia.
    Pavoni V; Gianesello L; Pazzi M; Stera C; Meconi T; Frigieri FC
    J Thromb Thrombolysis; 2020 Aug; 50(2):281-286. PubMed ID: 32394236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The haemostatic profile in critically ill COVID-19 patients receiving therapeutic anticoagulant therapy: An observational study.
    Tsantes AE; Frantzeskaki F; Tsantes AG; Rapti E; Rizos M; Kokoris SI; Paramythiotou E; Katsadiotis G; Karali V; Flevari A; Chrysanthopoulou E; Maratou E; Kyriakou E; Gialeraki A; Bonovas S; Dimopoulos G; Tsangaris I; Armaganidis A
    Medicine (Baltimore); 2020 Nov; 99(47):e23365. PubMed ID: 33217881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercoagulable viscoelastic blood clot characteristics in critically ill coronavirus disease 2019 patients and associations with thrombotic complications.
    Roh DJ; Eiseman K; Kirsch H; Yoh N; Boehme A; Agarwal S; Park S; Connolly ES; Claassen J; Wagener G
    J Trauma Acute Care Surg; 2021 Jan; 90(1):e7-e12. PubMed ID: 33009340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study.
    Shah A; Donovan K; McHugh A; Pandey M; Aaron L; Bradbury CA; Stanworth SJ; Alikhan R; Von Kier S; Maher K; Curry N; Shapiro S; Rowland MJ; Thomas M; Mason R; Holland M; Holmes T; Ware M; Gurney S; McKechnie SR
    Crit Care; 2020 Sep; 24(1):561. PubMed ID: 32948243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure.
    Spiezia L; Boscolo A; Poletto F; Cerruti L; Tiberio I; Campello E; Navalesi P; Simioni P
    Thromb Haemost; 2020 Jun; 120(6):998-1000. PubMed ID: 32316063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.
    Zhang Y; Cao W; Jiang W; Xiao M; Li Y; Tang N; Liu Z; Yan X; Zhao Y; Li T; Zhu T
    J Thromb Thrombolysis; 2020 Oct; 50(3):580-586. PubMed ID: 32648093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of Venous Thromboembolism in Critically Ill Coronavirus Disease 2019 Patients Receiving Prophylactic Anticoagulation.
    Trigonis RA; Holt DB; Yuan R; Siddiqui AA; Craft MK; Khan BA; Kapoor R; Rahman O
    Crit Care Med; 2020 Sep; 48(9):e805-e808. PubMed ID: 32618699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 coagulopathy vs disseminated intravascular coagulation.
    Levi M
    Blood Adv; 2020 Jun; 4(12):2850. PubMed ID: 32574369
    [No Abstract]   [Full Text] [Related]  

  • 13. Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.
    Bocci MG; Maviglia R; Consalvo LM; Grieco DL; Montini L; Mercurio G; Nardi G; Pisapia L; Cutuli SL; Biasucci DG; Gori C; Rosenkranz R; De Candia E; Carelli S; Natalini D; Antonelli M; Franceschi F
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12466-12479. PubMed ID: 33336766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboelastography findings in critically ill COVID-19 patients.
    Salem N; Atallah B; El Nekidy WS; Sadik ZG; Park WM; Mallat J
    J Thromb Thrombolysis; 2021 May; 51(4):961-965. PubMed ID: 33011896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.
    Panigada M; Bottino N; Tagliabue P; Grasselli G; Novembrino C; Chantarangkul V; Pesenti A; Peyvandi F; Tripodi A
    J Thromb Haemost; 2020 Jul; 18(7):1738-1742. PubMed ID: 32302438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability.
    Tan CW; Low JGH; Wong WH; Chua YY; Goh SL; Ng HJ
    Am J Hematol; 2020 Jul; 95(7):E156-E158. PubMed ID: 32267008
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System.
    Bilaloglu S; Aphinyanaphongs Y; Jones S; Iturrate E; Hochman J; Berger JS
    JAMA; 2020 Aug; 324(8):799-801. PubMed ID: 32702090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19).
    Salamanna F; Maglio M; Landini MP; Fini M
    Platelets; 2020 Jul; 31(5):627-632. PubMed ID: 32397915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19).
    Henry BM; Benoit SW; Hoehn J; Lippi G; Favaloro EJ; Benoit JL
    Semin Thromb Hemost; 2020 Oct; 46(7):859-862. PubMed ID: 32882718
    [No Abstract]   [Full Text] [Related]  

  • 20. Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)?
    Dorgalaleh A; Dabbagh A; Tabibian S; Baghaeipour MR; Jazebi M; Bahraini M; Fazeli S; Rad F; Baghaeipour N
    Semin Thromb Hemost; 2020 Oct; 46(7):853-855. PubMed ID: 32557449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.